Morning Average True Range under Consideration: Harpoon Therapeutics, Inc. (NASDAQ:HARP -2.58%), Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK 7.12%)

There are two main reasons why moving averages are useful in forex trading:

  • moving averages help traders define trend
  • recognize changes in trend.

Now well have a look on, SMA50 & SMA200

The 50-day simple moving average (SMA) is used by traders as an effective trend indicator.

HARP has seen its SMA50 which is now -14.66%. In looking the SMA 200 we see that the stock has seen a -41.29%.

PRTK has seen its SMA50 which is now 41.49%. In looking the SMA 200 we see that the stock has seen a 18.15%.


Now as an added measure to ensure you only trade with the main trend, the 200 SMA can be used a further filter.

  • if 10 and 20 SMA are above the 200 SMA only take long positions.
  • if 10 and 20 SMA are below the 200 SMA only take short positions.

On 04-03-2023 (Monday) Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP) encountered a difference of -2.58% after which it shut the day’ session at $0.73. The volume added 66,158 shares which compares with the average volume of 459.99K shares.

Harpoon Therapeutics, Inc., a USA based Company, belongs to Biotechnology sector industry. Shares of Harpoon Therapeutics, Inc. was among the active stocks of the last exchanging sessions.


The stock value instability stayed at 10.60% in recent month and ranges at 8.72% for the week. The Average True Range (ATR) is also a measure of volatility is presently sitting at 0.07. The firm demonstrates the market capitalization of $25.91M.

Important Results:

Harpoon Therapeutics, Inc. has P/S value of 0.81 while its P/B esteem remains at 4.65. Likewise, the company has Return on Assets of -38.30%, Return on Equity of -299.90% and Return on Investment of 0. The company demonstrates Gross Margin and Operating Margin of 0 and 0 respectively.

Forward P/E of Harpoon Therapeutics, Inc. is remaining at 0. Forward P/E is a measure of the price-to-earnings ratio using forecasted earnings for the P/E calculation for the next fiscal year.

Technical Analysis of Harpoon Therapeutics, Inc. HARP:

The stock price moved with change of 18.85% to its 50 Day low spot and changed -50.00% contrasting with its 50 Day high point. HARP stock is as of now appearing down return of 11.03% all through a week ago and saw bearish return of -7.18% in one month span. The execution of company -0.10% in three months and -25.27% throughout the previous a half year exchanging period.

Tracking the closing price and 52-week high, the current price movement shows that the stock price positioned negative when compared against the 52-week high. As close of recent trade, stock represents -85.95%move from 52-week high. Tracing the 52-week low position of the stock, we noted that the closing price represents a 23.78% higher distance from that low value. Technical analysts compare a stock’s current trading price to its 52-week range to get a broad sense of how the stock is doing, as well as how much the stock’s price has fluctuated. This information may indicate the potential future range of the stock and how volatile the shares are.

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK)’s Analysis & Performances to Discover

On 04-03-2023 (Monday), Paratek Pharmaceuticals, Inc., belongs to Healthcare sector and Biotechnology industry. The company’s total Outstanding Shares of 55.75M. PRTK flaunted 7.12% to reach at $2.72 during previous trading session. The company has experienced volume of 578,228 shares while on average the company has a capacity of trading 570.99K share.

Observing the Technical Indicators:

Paratek Pharmaceuticals, Inc. institutional ownership is held at 46.40% while insider ownership was 7.10%. As of now, PRTK has a P/S, P/E and P/B values of 0.76, 0 and 0 respectively. Its P/Cash is valued at 3.55.

The Company’s net profit margin for the 12 months at -39.70%. Comparatively, the gazes have a Gross margin 85.60%.

Profitability ratios:

Looking into the profitability ratios of PRTK stock, an investor will find its ROE, ROA, ROI standing at 40.60%, -38.30% and -53.90%, respectively.

Reading RSI Indicator

Paratek Pharmaceuticals, Inc. (PRTK) attained alert from day Traders as RSI reading reached at 71.78. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30. Signals can also be generated by looking for divergences, failure swings, and centerline crossovers. RSI can also be used to identify the general trend. These traditional levels can also be adjusted to better fit the security or analytical requirements. Raising overbought to 80 or lowering oversold to 20 will reduce the number of overbought/oversold readings. Short-term traders sometimes use 2-period RSI to look for overbought readings above 80 and oversold readings below 20.

Earnings per Share Details of Paratek Pharmaceuticals, Inc.:

The EPS of PRTK is strolling at -1.18, measuring its EPS growth this year at 4.20%. As a result, the company has an EPS growth of 107.40% for the approaching year.

Given the importance of identifying companies that will ensure earnings per share at a tall rate, we later obsession to umpire how to identify which companies will achieve high amassing rates. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years.

What Does the Payout Ratio Tell You?

The payout ratio is a key financial metric used to determine the sustainability of a company’s dividend payments. It is the amount of dividends paid to shareholders relative to the total net income of a company.

Formula for the Payout Ratio Is

“Payout Ratio = Dividends / Earnings”

Is It Overvalued? Look at the Payout Ratio of HARP, PRTK

The payout ratio shows the proportion of earnings paid out as dividends to shareholders, typically expressed as a percentage of the company’s earnings. The payout ratio can also be expressed as dividends paid out as a proportion of cash flow. The payout ratio is also known as the dividend payout ratio. HARP has a Payout Ratio of 0 and PRTK has a Payout Ratio of 0.

47 Comments on “Morning Average True Range under Consideration: Harpoon Therapeutics, Inc. (NASDAQ:HARP -2.58%), Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK 7.12%)”

  1. Does your website have a contact page? I’m having trouble locating it but, I’d like to send you
    an e-mail. I’ve got some recommendations for your blog you
    might be interested in hearing. Either way, great website
    and I look forward to seeing it expand over time.

  2. My partner and I absolutely love your blog and find almost all of your post’s to be what precisely I’m looking for.
    Does one offer guest writers to write content available for you?
    I wouldn’t mind composing a post or elaborating on a number of the subjects you write in relation to here.
    Again, awesome website!

  3. Hi there very nice site!! Guy .. Excellent .. Amazing ..
    I will bookmark your website and take the feeds also?
    I am happy to search out a lot of helpful information right here within the submit, we want develop more strategies in this regard, thank you for sharing.
    . . . . .

  4. I like the helpful information you provide in your articles.
    I will bookmark your weblog and check again here frequently.
    I am quite sure I’ll learn many new stuff right here! Best of luck for the next!

  5. Excellent goods from you, man. I’ve understand your stuff previous to and you are just too magnificent.
    I actually like what you’ve acquired here, really like what you’re saying and the way in which you say it.
    You make it enjoyable and you still care for to keep it wise.

    I can’t wait to read far more from you. This is really a terrific site.

  6. This is the right site for anybody who would like to find out about this topic. You understand so much its almost hard to argue with you (not that I actually would want toHaHa). You definitely put a new spin on a topic that has been written about for a long time. Excellent stuff, just excellent!

  7. I was wondering if you ever considered changing the layout of your site? Its very well written; I love what youve got to say. But maybe you could a little more in the way of content so people could connect with it better. Youve got an awful lot of text for only having one or two images. Maybe you could space it out better?

  8. Tremendous things here. I’m very satisfied to peer your article. Thank you so much and I’m taking a look forward to touch you. Will you please drop me a mail?

  9. Wow that was odd. I just wrote an extremely long comment but after I clicked submit my comment didn’t show up. Grrrr… well I’m not writing all that over again. Anyway, just wanted to say superb blog!

  10. Hey I know this is off topic but I was wondering if you knew of any widgets I could add to my blog that automatically tweet my newest twitter updates. I’ve been looking for a plug-in like this for quite some time and was hoping maybe you would have some experience with something like this. Please let me know if you run into anything. I truly enjoy reading your blog and I look forward to your new updates.

  11. Hi there I am so excited I found your weblog, I really found you by mistake, while I was browsing on Askjeeve for something else, Anyhow I am here now and would just like to say kudos for a remarkable post and a all round interesting blog (I also love the theme/design), I dont have time to browse it all at the minute but I have saved it and also added in your RSS feeds, so when I have time I will be back to read much more, Please do keep up the excellent jo.

  12. Hi this is somewhat of off topic but I was wondering if blogs use WYSIWYG editors or if you have to manually code with HTML. I’m starting a blog soon but have no coding experience so I wanted to get advice from someone with experience. Any help would be greatly appreciated!

Leave a Reply

Your email address will not be published. Required fields are marked *